Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Towa Pharmaceutical Co ( (JP:4553) ) has provided an update.
Towa Pharmaceutical Co., Ltd. reported significant financial growth for the nine months ending December 31, 2024, with notable year-on-year increases in net sales, operating profit, and ordinary profit. The company also revised its dividend forecast, reflecting its positive performance and strategic decisions to enhance shareholder value. This financial performance underscores Towa’s strengthening position in the pharmaceutical industry, potentially impacting its market competitiveness and stakeholder interests.
More about Towa Pharmaceutical Co
Towa Pharmaceutical Co., Ltd. is a company based in Japan, listed on the Tokyo Stock Exchange, with a focus on the pharmaceutical industry. The company specializes in the development and sale of generic drugs, serving both domestic and international markets.
YTD Price Performance: -8.73%
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $936.4M
Find detailed analytics on 4553 stock on TipRanks’ Stock Analysis page.
